Stephen Taub Premium Where EcoR1 Stands to Profit From Healthy Deal Making Biopharma companies backed by EcoR1 Capital have filed plans this week for public offerings. Stephen Taub November 13, 2020 Oleg Nodelman (Amanda Gordon/Bloomberg)